Breakthrough Technology Revolutionising
Point-of-care DiagnosticsVivacta is a world class medical diagnostics company with a revolutionary technology platform for rapid, quantitative, high-performance point-of-care diagnostic tests, that can deliver extremely sensitive and accurate results equivalent to laboratory testing close to the patient within 10 minutes. Each diagnostic test requires only a single pin prick of whole blood.

Vivacta has successfully developed a diagnostic test for thyroid stimulating hormone (TSH), one of the most widely prescribed diagnostic tests globally. Vivacta's test has been proven to perform as well as the industry's laboratory-based gold standard for TSH testing, demonstrating the high sensitivity, wide dynamic range, precision and speed to result enabled by the technology.

The Company's strategy is to establish collaborations with healthcare companies to develop point-of-care diagnostics for applications in acute, chronic and home care, where rapid and accurate test results are needed.

Vivacta is led by a highly experienced Management team with a proven track record in the healthcare industry and is guided by an accomplished Board of Directors.